Arcadu F, Benmansour F, Maunz A, et al. Deep learning algorithm predicts diabetic retinopathy progression in individual patients. NPJ Digit Med. 2019;2:92.
Aslam TM, Zaki HR, Mahmood S, et al. Use of a neural net to model the impact of optical coherence tomography abnormalities on vision in age-related macular degeneration. Am J Ophthalmol. 2018;185:94‐100.
Balyen L, Peto Tunde. Promising artificial intelligence-machine learning-deep learning algorithms in ophthalmology. Asia Pac J Ophthalmol ( Phila). 2019;8:264-272.
Berchuck SI, Mukherjee S, Medeiros FA. Estimating rates of progression and predicting future visual fields in glaucoma using a deep variational autoencoder. Sci Rep. 2019;9:18113.
Briganti G, Le Moine O. Artificial intelligence in medicine: today and tomorrow. Front Med (Lausanne). 2020;7:27.
Cabitza F, Zeitoun JD. The proof of the pudding: in praise of a culture of real-world validation for medical artificial intelligence. Ann Transl Med. 2019;7:161.
Davenport T, Kalakota R. The potential for artificial intelligence in healthcare. Future Healthc J. 2019;6:94‐98.
Du XL, Li WB, Hu BJ. Application of artificial intelligence in ophthalmology. Int J Ophthalmol. 2018;11:1555‐1561.
Hilton CB, Milinovich A, Felix C, et al. Personalized predictions of patient outcomes during and after hospitalization using artificial intelligence. NPJ Digit Med. 2020;3:51.
Jammal AA, Thompson AC, Mariottoni EB, et al. Human versus machine: comparing a deep learning algorithm to human gradings for detecting glaucoma on fundus photographs. Am J Ophthalmol. 2020;211:123‐131.
Li Z, He Y, Keel S, et al. Efficacy of a deep learning system for detecting glaucomatous optic neuropathy based on color fundus photographs. Ophthalmology. 2018;125:1199‐1206.
Liu X, Faes L, Kale AU, et al. A comparison of deep learning performance against health-care professionals in detecting diseases from medical imaging: a systematic review and meta-analysis. Lancet Digital Health. 2019;1:E271-297.
Lu W, Tong Y, Yu Y, et al. Applications of artificial intelligence in ophthalmology: general overview. J Ophthalmol. 2018;2018:5278196.
Maetschke S, Antony B, Ishikawa H, et al. A feature agnostic approach for glaucoma detection in OCT volumes. PLoS One. 2019;14:e0219126.
Phene S, Dunn RC, Hammel N, et al. Deep learning and glaucoma specialists: the relative importance of optic disc features to predict glaucoma referral in fundus photographs. Ophthalmology. 2019;126:1627‐1639.
Rong G, Mendez A, Assi EB, et al. Artificial intelligence in healthcare: review and prediction case studies. Engineering. 2020;6:291-301.
Schmidt-Erfuth U, Sadeghipour A, Gerendas BS, et al. Artificial intelligence in retina. Prog Retin Eye Res. 2018;67:1‐29.
Spaide T, Wu Y, Yanagihara RT, et al. Using deep learning to automate Goldmann applanation tonometry readings. Ophthalmology. 2020;S0161-6420(20)30412-7.
Ting DSW, Lee AY, Wong TY. An ophthalmologist's guide to deciphering studies in artificial intelligence. Ophthalmology. 2019;126:1475‐1479.

WebMD Global requires each individual who is in a position to control the content of one of its educational activities to disclose any relevant financial relationships occurring within the past 12 months that could create a conflict of interest.

Moderator

Richard F. Spaide, MD

Vitreous, Retina, Macula Consultants of New York
New York, New York, United States

Disclosures

Disclosure: Richard R. Spaide, MD, has disclosed the following relevant financial relationships:
Served as an advisor or consultant for: Bayer HealthCare; Genentech, Inc.; Heidelberg Engineering; Novartis Pharmaceuticals Corporation; Roche Holdings AG; Topcon Medical Systems

Panelists

Aaron Lee, MD, MSc

Assistant Professor
Department of Ophthalmology
University of Washington
Seattle, Washington, United States

Disclosures

Disclosure: Aaron Lee, MD, MSc, has disclosed the following relevant financial relationships:
Served as an advisor or consultant for: Genentech, Inc.; Topcon; Verana Health
Received grants for clinical research from: Carl Zeiss; Microsoft; NVIDIA; Santen

Tariq Aslam, DM, FRCSEd, MBChB, PhD

Consultant Ophthalmologist
Division of Pharmacy and Optometry
University of Manchester
Manchester, United Kingdom

Disclosures

Served as an advisor or consultant for: Allergan, Inc.; Bausch & Lomb Inc.; Bayer HealthCare; Novartis Pharmaceuticals Corporation; Thea Pharmaceuticals
Served as a speaker or a member of a speakers bureau for: Allergan, Inc.; Bausch & Lomb Inc.; Bayer HealthCare; Novartis Pharmaceuticals Corporation; Thea Pharmaceuticals; Topcon
Received grants for clinical research from: Bayer HealthCare; Canon; Thea Pharmaceuticals

Editors

Shanthi Voorn, PhD

Medical Education Director, WebMD Global, LLC

Disclosures

Disclosure: Shanthi Voorn, PhD, has disclosed no relevant financial relationships.

Yoji Yamaguchi, MA

Associate Scientific Content Manager, WebMD Global, LLC

Disclosures

Disclosure: Yoji Yamaguchi, MA, has disclosed no relevant financial relationships.

Content Reviewers

Dr Laura Blackburn

Head of Science, PHG Foundation

Disclosures

Dr Laura Blackburn has disclosed no relevant financial relationships.

Robert Morris, PharmD

Associate Director, Accreditation and Compliance

Disclosures

Disclosure: Robert Morris, PharmD, has disclosed the following relevant financial relationships:
Served as an advisor or consultant for: ViiV Healthcare
Owns stock, stock options, or bonds from: GlaxoSmithKline

CPD

Overcoming Challenges in Ophthalmology: Using Artificial Intelligence to Personalize Care

Authors: Richard F. Spaide, MD; Aaron Lee, MD, MSc; Tariq Aslam, DM, FRCSEd, MBChB, PhD
CPD Released: 6/30/2020
THIS ACTIVITY HAS EXPIRED FOR CREDIT
Valid for credit through: 6/30/2021, 11:59 PM EST

Start Activity

Target Audience and Goal Statement

This educational activity is intended for an international audience of non-US ophthalmologists.

The goal of this activity is to increase clinicians' knowledge of the latest data on the use of deep learning (DL) systems in the diagnosis and prognosis of eye diseases such as diabetic retinopathy and age-related macular degeneration, as well as the challenges and ethical considerations surrounding the use of artificial intelligence (AI) in ophthalmology.

Upon completion of this activity, participants will:

Have increased knowledge regarding the
- DL approaches being used in ophthalmology imaging to aid in the diagnosis or prognosis of conditions that cause blindness
- Advances in digital monitoring for conditions that cause blindness
- Challenges in implementing DL approaches in ophthalmology

Disclosures

Moderator

Richard F. Spaide, MD

Vitreous, Retina, Macula Consultants of New York
New York, New York, United States

Disclosures

Disclosure: Richard R. Spaide, MD, has disclosed the following relevant financial relationships:
Served as an advisor or consultant for: Bayer HealthCare; Genentech, Inc.; Heidelberg Engineering; Novartis Pharmaceuticals Corporation; Roche Holdings AG; Topcon Medical Systems

Panelists

Aaron Lee, MD, MSc

Assistant Professor
Department of Ophthalmology
University of Washington
Seattle, Washington, United States

Disclosures

Disclosure: Aaron Lee, MD, MSc, has disclosed the following relevant financial relationships:
Served as an advisor or consultant for: Genentech, Inc.; Topcon; Verana Health
Received grants for clinical research from: Carl Zeiss; Microsoft; NVIDIA; Santen

Tariq Aslam, DM, FRCSEd, MBChB, PhD

Consultant Ophthalmologist
Division of Pharmacy and Optometry
University of Manchester
Manchester, United Kingdom

Disclosures

Served as an advisor or consultant for: Allergan, Inc.; Bausch & Lomb Inc.; Bayer HealthCare; Novartis Pharmaceuticals Corporation; Thea Pharmaceuticals
Served as a speaker or a member of a speakers bureau for: Allergan, Inc.; Bausch & Lomb Inc.; Bayer HealthCare; Novartis Pharmaceuticals Corporation; Thea Pharmaceuticals; Topcon
Received grants for clinical research from: Bayer HealthCare; Canon; Thea Pharmaceuticals

Editors

Shanthi Voorn, PhD

Medical Education Director, WebMD Global, LLC

Disclosures

Disclosure: Shanthi Voorn, PhD, has disclosed no relevant financial relationships.

Yoji Yamaguchi, MA

Associate Scientific Content Manager, WebMD Global, LLC

Disclosures

Disclosure: Yoji Yamaguchi, MA, has disclosed no relevant financial relationships.

Content Reviewers

Dr Laura Blackburn

Head of Science, PHG Foundation

Disclosures

Dr Laura Blackburn has disclosed no relevant financial relationships.

Robert Morris, PharmD

Associate Director, Accreditation and Compliance

Disclosures

Disclosure: Robert Morris, PharmD, has disclosed the following relevant financial relationships:
Served as an advisor or consultant for: ViiV Healthcare
Owns stock, stock options, or bonds from: GlaxoSmithKline

Accreditation Statements

For Physicians

The Faculty of Pharmaceutical Medicine of the Royal Colleges of Physicians of the United Kingdom (FPM) has reviewed and approved the content of this educational activity and allocated it .25 continuing professional development credits (CPD).

Contact WebMD Global

For questions regarding the content of this activity, contact the accredited provider for this CME/CE activity noted above. For technical assistance, contact [email protected]

Instructions for Participation and Credit

There are no fees for participating in or receiving credit for this online educational activity. For information about your eligibility to claim credit, please consult your professional licensing board.

This activity is designed to be completed within the time designated on the title page; physicians should claim only those credits that reflect the time actually spent participating in the activity. To successfully earn credit, participants must complete the activity online during the credit eligibility period that is noted on the title page.

Follow these steps to claim a credit certificate for completing this activity:

Read the information provided on the title page regarding the target audience, learning objectives, and author disclosures, read and study the activity content and then complete the post-test questions. If you earn a passing score on the post-test and we have determined based on your registration profile that you may be eligible to claim CPD credit for completing this activity, we will issue you a CPD credit certificate.
Once your CPD credit certificate has been issued, you may view and print the certificate from your CME/CE Tracker. CPD credits will be tallied in your CME/CE Tracker and archived for 6 years; at any point within this time period you can print out the tally as well as the certificates by accessing "Edit Your Profile" at the top of the Medscape Education homepage.

We encourage you to complete an Activity Evaluation to provide feedback for future programming.

You may now view or print the certificate from your CME/CE Tracker. You may print the certificate but you cannot alter it. Credits will be tallied in your CME/CE Tracker and archived for 6 years; at any point within this time period you can print out the tally as well as the certificates by accessing "Edit Your Profile" at the top of your Medscape homepage.

*The credit that you receive is based on your user profile.

From Medscape Education

CPD

Overcoming Challenges in Ophthalmology: Using Artificial Intelligence to Personalize Care

Authors: Richard F. Spaide, MD; Aaron Lee, MD, MSc; Tariq Aslam, DM, FRCSEd, MBChB, PhDFaculty and Disclosures

THIS ACTIVITY HAS EXPIRED FOR CREDIT

CPD Released: 6/30/2020

Valid for credit through: 6/30/2021, 11:59 PM EST

processing....

Abbreviations

AI = artificial intelligence
AMD = age-related macular degeneration
CFP = color fundus photograph
DL = deep learning
DR = diabetic retinopathy
EHR = electronic health record
ELM = external limiting membrane
IOP = intraocular pressure
ML = machine learning
nAMD = neovascular age-related macular degeneration
NHS = National Health Service
NICE = National Institute for Health and Care Excellence
OCT = optical coherence tomography
OCTA = optical coherence tomography angiography
RSM = root square mean
VA = visual acuity
VEGF = vascular endothelial growth factor